BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 26512838)

  • 1. Peripheral arterial disease and atrial fibrillation and risk of stroke, heart failure hospitalization and cardiovascular death: A nationwide cohort study.
    Lin YS; Tung TH; Wang J; Chen YF; Chen TH; Lin MS; Chi CC; Chen MC
    Int J Cardiol; 2016 Jan; 203():204-11. PubMed ID: 26512838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.
    Winkel TA; Hoeks SE; Schouten O; Zeymer U; Limbourg T; Baumgartner I; Bhatt DL; Steg PG; Goto S; Röther J; Cacoub PP; Verhagen HJ; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2010 Jul; 40(1):9-16. PubMed ID: 20385507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AF.
    Jones WS; Hellkamp AS; Halperin J; Piccini JP; Breithardt G; Singer DE; Fox KA; Hankey GJ; Mahaffey KW; Califf RM; Patel MR
    Eur Heart J; 2014 Jan; 35(4):242-9. PubMed ID: 24302273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular Disease and Risk Stratification for Ischemic Stroke and All-Cause Death in Heart Failure Patients without Diagnosed Atrial Fibrillation: A Nationwide Cohort Study.
    Melgaard L; Gorst-Rasmussen A; Rasmussen LH; Lip GY; Larsen TB
    PLoS One; 2016; 11(3):e0152269. PubMed ID: 27015524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks of Death and Stroke in Patients Undergoing Hemodialysis With New-Onset Atrial Fibrillation: A Competing-Risk Analysis of a Nationwide Cohort.
    Shih CJ; Ou SM; Chao PW; Kuo SC; Lee YJ; Yang CY; Tarng DC; Lin CC; Huang PH; Li SY; Chen YT
    Circulation; 2016 Jan; 133(3):265-72. PubMed ID: 26680239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower Extremity Arterial Disease as a Predictor of Incident Atrial Fibrillation and Cardiovascular Events.
    Tseng AS; Girardo M; Firth C; Bhatt S; Liedl D; Wennberg P; Shen WK; Cooper LT; Shamoun FE
    Mayo Clin Proc; 2021 May; 96(5):1175-1183. PubMed ID: 33958054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender Differences in the Risk of Adverse Outcomes in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction.
    O'Neal WT; Sandesara P; Hammadah M; Venkatesh S; Samman-Tahhan A; Kelli HM; Soliman EZ
    Am J Cardiol; 2017 Jun; 119(11):1785-1790. PubMed ID: 28395886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial Fibrillation Increases the Risk of Peripheral Arterial Disease With Relative Complications and Mortality: A Population-Based Cohort Study.
    Chang CJ; Chen YT; Liu CS; Lin WY; Lin CL; Lin MC; Kao CH
    Medicine (Baltimore); 2016 Mar; 95(9):e3002. PubMed ID: 26945422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
    Holmqvist F; Guan N; Zhu Z; Kowey PR; Allen LA; Fonarow GC; Hylek EM; Mahaffey KW; Freeman JV; Chang P; Holmes DN; Peterson ED; Piccini JP; Gersh BJ;
    Am Heart J; 2015 May; 169(5):647-654.e2. PubMed ID: 25965712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients With Ischemic Stroke and Incident Atrial Fibrillation: A Nationwide Cohort Study.
    Fauchier L; Clementy N; Pelade C; Collignon C; Nicolle E; Lip GY
    Stroke; 2015 Sep; 46(9):2432-7. PubMed ID: 26251249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral arterial disease is associated with an increased risk of atrial fibrillation in the elderly.
    Griffin WF; Salahuddin T; O'Neal WT; Soliman EZ
    Europace; 2016 Jun; 18(6):794-8. PubMed ID: 26589625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Bansal N; Xie D; Sha D; Appel LJ; Deo R; Feldman HI; He J; Jamerson K; Kusek JW; Messe S; Navaneethan SD; Rahman M; Ricardo AC; Soliman EZ; Townsend R; Go AS
    J Am Soc Nephrol; 2018 Dec; 29(12):2859-2869. PubMed ID: 30377231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of radiofrequency catheter ablation for atrial fibrillation on morbidity and mortality: a nationwide cohort study and propensity score analysis.
    Chang CH; Lin JW; Chiu FC; Caffrey JL; Wu LC; Lai MS
    Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):76-82. PubMed ID: 24446025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral arterial disease and risk of atrial fibrillation and stroke: the Multi-Ethnic Study of Atherosclerosis.
    O'Neal WT; Efird JT; Nazarian S; Alonso A; Heckbert SR; Soliman EZ
    J Am Heart Assoc; 2014 Nov; 3(6):e001270. PubMed ID: 25404190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.
    Olsson LG; Swedberg K; Ducharme A; Granger CB; Michelson EL; McMurray JJ; Puu M; Yusuf S; Pfeffer MA;
    J Am Coll Cardiol; 2006 May; 47(10):1997-2004. PubMed ID: 16697316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 30-year nationwide trends in incidence of atrial fibrillation in Denmark and associated 5-year risk of heart failure, stroke, and death.
    Schmidt M; Ulrichsen SP; Pedersen L; Bøtker HE; Nielsen JC; Sørensen HT
    Int J Cardiol; 2016 Dec; 225():30-36. PubMed ID: 27705839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of stroke and heart failure attributable to atrial fibrillation in middle-aged and elderly people: Results from a five-year prospective cohort study of Japanese community dwellers.
    Ohsawa M; Okamura T; Tanno K; Ogasawara K; Itai K; Yonekura Y; Konishi K; Omama S; Miyamatsu N; Turin TC; Morino Y; Itoh T; Onoda T; Sakata K; Ishibashi Y; Makita S; Nakamura M; Tanaka F; Kuribayashi T; Ohta M; Okayama A
    J Epidemiol; 2017 Aug; 27(8):360-367. PubMed ID: 28390793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic treatment in patients with heart failure and associated atrial fibrillation and vascular disease: a nationwide cohort study.
    Lamberts M; Lip GY; Ruwald MH; Hansen ML; Özcan C; Kristensen SL; Køber L; Torp-Pedersen C; Gislason GH
    J Am Coll Cardiol; 2014 Jun; 63(24):2689-98. PubMed ID: 24794118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
    Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
    JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation is a risk marker for worse in-hospital and long-term outcome in patients with peripheral artery disease.
    Wasmer K; Unrath M; Köbe J; Malyar NM; Freisinger E; Meyborg M; Breithardt G; Eckardt L; Reinecke H
    Int J Cardiol; 2015 Nov; 199():223-8. PubMed ID: 26209823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.